Institut Jantung Negara (IJN) was established in 1992, as a cardiovascular and thoracic center. It has always tried to keep abreast with current advances and benchmarked with internationally acclaimed, established, advanced centers.
It has kept itself of international standards in quality in healthcare, presently accredited Joint Commission International JCI, Malaysian Society for Quality in Healthcare MSQH 3rd edition 2008 and ISO 9001:2008.
In our attempts to keep abreast with advances in cardiovascular and thoracic medicine, some of the recent procedures, surgeries, services, program are illustrated below:
Services:
Catheter-based Mitral Valve Repair with the MITRACLIP
Mitral regurgitation (MR) is a condition whereby the mitral valve leaks. As a result, a significant volume of blood is pushed backward into the left atrium. Left unattended, mitral regurgitation can lead to progressive enlargement of the heart and will lead to heart failure. Common causes for these leakages are usually either functional or degenerative. Conventional treatment of severe MR will be surgery, in the form of either mitral valve repair or replacement. However, this will require an open heart surgery. On occasions, the risk of surgery is high especially when there is coexisting medical conditions or advanced age.
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched ‘MYSalam’ scheme; a healthcare programme which aims to provide coverage to the country’s bottom 40 percent of earners.…
After 61 years of single-party rule, the May 2018 electoral victory of the populist Pakatan Harapan (PH) coalition sent shockwaves through the Malaysian political landscape. This has been keenly felt…
Click here to download the Healthcare & Life Sciences Review Malaysia 2018. After recent elections conducted in May 2018 saw Mahathir Mohamad returning as Prime Minister after 15 years to…
American medtech giant Baxter and pan-Asian healthcare service provider Zuellig Pharma have been collaborating in Malaysia to increase the quality and quantity of care that can be given to patients…
Sherene Azli, CEO of the Malaysia Healthcare Travel Council (MHTC), introduces this unique organization in charge of promoting Malaysia internationally as the ‘Cardiology and Fertility Hub of Asia’ and explains…
Rashidah Ibrahim, executive director of Malaysian Vaccines & Pharmaceuticals (MVP), tells the story of MVP as the sole animal vaccines manufacturer in Malaysia. She also explains how important animal health…
Chuwn Leong Ch’ng, CEO of Thunder Print, presents his company’s strategic role within the Malaysian healthcare industry to provide a high-quality packaging services for all type of health products, from…
Robert Kruit, chief executive for Zuellig Malaysia and Brunei, discusses Zuellig’s plans to expand beyond distribution and diversify its offering in the healthcare sector, and how Zuellig’s investments into digital…
Tan Sri Dato’ Ariffin Yusuf, founder and managing director of Primabumi, explains how he came to build Primabumi in 1975 and how he managed to position the company as a…
Halal pharmaceuticals – medicines that do not contain any alcohol, parts of animals such as dogs, pigs, bees, or any other substances prohibited as ‘haram’ under Shariah law – are…
Lee Yee Keng, head of healthcare sector of KPMG in Malaysia, highlights the opportunities Malaysia can offer to the healthcare industry, including its potential for private-public partnerships, and how the…
See our Cookie Privacy Policy Here
